[1] |
Primavera A, Cocito L, Audenino D. Nonconvulsive status epilepticus during cephalosporin therapy [J]. Neuropsychobiology, 2004, 49(4): 218-222.
|
[2] |
Chang YM. Cefepime-induced nonconvulsive status epilepticus as a cause of confusion in an elderly patient [J]. J Formos Med Assoc, 2015, 114(3): 290-291.
|
[3] |
Martin TCS, Chow S, Johns ST, et al. Ceftaroline-associated encephalopathy in patients with severe renal impair ment [J]. Clin Infect Dis, 2020, 70(9): 2002-2004.
|
[4] |
Fugate JE, Kalimullah EA, Hocker SE, et al. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy [J]. Crit Care, 2013, 17(6): R264.
|
[5] |
Sonck J, Laureys G, Verbeelen D. The neurotoxicity and safety of treatment with cefepime in patients with renal failure [J]. Nephrol Dial Transplant, 2008, 23(3): 966-970.
|
[6] |
张佩殷,黄新忠,范亚平,等. 慢性肾脏病并发抗生素脑病的危险因素及防治[J]. 中国现代医学杂志,2014, 24(15): 90-93.
|
[7] |
龚昌华,叶树位. 终末期肾脏病患者应用头孢他啶后并发抗生素脑病的相关性分析[J]. 中国药房,2015, 26(36): 5083-5084.
|
[8] |
郭爱莉. 头孢菌素致慢性肾衰竭患者抗生素脑病25例回顾性分析[J]. 药物流行病学杂志,2015(4): 228-230.
|
[9] |
Nakagawa R, Sato K, Uesaka Y, et al. Cefepime-induced encephalopathy in end-stage renal disease patients [J]. J Neurol Sci, 2017, 376: 123-128.
|
[10] |
Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside [J]. Eur J Clin Microbiol Infect Dis, 2005, 24(10): 649-653.
|
[11] |
Garces EO, Andrade de Anzambuja MF, da Silva D, et al. Renal failure is a risk factor for cefepime-induced encephalopathy [J]. J Nephrol, 2008, 21(4): 526-534.
|
[12] |
Zhang J, Huang C, Li H, et al. Antibiotic-induced neurotoxicity in dialysis patients: a retrospective study [J]. Ren Fail, 2013, 35(6): 901-905.
|
[13] |
Kim KB, Kim SM, Park W, et al. Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review [J]. J Korean Med Sci, 2012, 27(9): 1120-1123.
|
[14] |
Sato Y, Morita H, Wakasugi H, et al. Reversible choreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease [J]. Am J Med Sci, 2010, 340(5): 382-384.
|
[15] |
Tan ML, Tun WWW. Reversible choreoathetosis in a patient with end-stage renal disease from administration of ceftriaxone [J]. Cureus, 2019, 11(9): e5764.
|
[16] |
Suzuki S, Naito S, Numasawa Y, et al. Encephalopathy induced by high plasma and cerebrospinal fluid ceftriaxone concentrations in a hemodialysis patient [J]. Intern Med, 2019, 58(12): 1775-1779.
|
[17] |
Jallon P, Fankhauser L, Du Pasquier R, et al. Severe but reversible encephalopathy associated with cefepime [J]. Neurophysiol Clin, 2000, 30(6): 383-386.
|
[18] |
Guo Y, Shao X, Zhang L, et al. A case of suspected antibiotic-associated encephalopathy in a patient undergoing long-term peritoneal dialysis [J]. J Int Med Res, 2020, 48(5): 300060520924507.
|
[19] |
Lattanzio F, Landi F, Bustacchini S, et al. Geriatric conditions and the risk of adverse drug reactions in older adults: a review [J]. Drug Saf, 2012, 35(Suppl 1): 55-61.
|
[20] |
黄玉斌,李赞东. 国内外头孢吡肟不良反应综述[J]. 中国执业药师,2016,13(5): 32-35.
|
[21] |
Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review [J]. Clin Ther, 2014, 36(11): 1489-1511.
|
[22] |
贺瑞萍,郭永英. 抗生素类药物对神经系统的毒性反应[J]. 中国药事,2004, 18(12): 774-775.
|
[23] |
Alkharfy KM, Kellum JA, Frye RF, et al. Effect of ceftazidime on systemic cytokine concentrations in rats [J]. Antimicrob Agents Chemother, 2000, 44(11): 3217-3219.
|
[24] |
Sunagawa M, Matsumura H, Sumita Y, et al. Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain [J]. J Antibiot (Tokyo), 1995, 48(5): 408-416.
|
[25] |
De Sarro A, Imperatore C, Mastroeni P, et al. Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice [J]. J Pharm Pharmacol, 1995, 47(4): 292-296.
|
[26] |
Weihrauch TR, Köhler H, Höffler D. Cerebral toxicity of penicillins in relation to their hydrophobic character [J]. Naunyn Schmiedebergs Arch Pharmacol, 1975, 289(1): 55-64.
|
[27] |
唐学文,贾运涛,田晓江,等. 左氧氟沙星、莫西沙星和环丙沙星上市后安全警戒信号的挖掘与评价——基于真实世界不良反应研究[J]. 中国新药杂志,2018, 27(5): 596-602.
|
[28] |
Calandra G, Lydick E, Carrigan J, et al. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin [J]. Am J Med, 1988, 84(5): 911-918.
|
[29] |
Chow KM, Szeto CC, Hui AC, et al. Mechanisms of antibiotic neurotoxicity in renal failure [J]. Int J Antimicrob Agents, 2004, 23(3): 213-217.
|
[30] |
Nau R, Sörgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections [J]. Clin Microbiol Rev, 2010, 23(4): 858-883.
|
[31] |
Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring [J]. Ann Pharmacother, 2008, 42(12): 1843-1850.
|
[32] |
Huang WT, Hsu YJ, Chu PL, et al. Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure [J]. Infection, 2009, 37(4): 374-376.
|
[33] |
Schliamser SE, Cars O, Norrby SR. Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis [J]. J Antimicrob Chemother, 1991, 27(4): 405-425.
|
[34] |
Brouns R, De Deyn PP. Neurological complications in renal failure: a review [J]. Clin Neurol Neurosurg, 2004, 107(1): 1-16.
|
[35] |
马雁,沈皓. 头孢吡肟致尿毒症维持性血液透析患者抗生素脑病的临床分析[J]. 临床内科杂志,2012, 29(9): 612-613.
|
[36] |
彭梅,汪贤聪,罗凯,等. 尿毒症患者抗生素脑病23例临床分析[J]. 实用医院临床杂志,2012, 9(5): 202-203.
|